A Nursing Guide to Infusion Therapy with Abatacept for the Treatment of Rheumatoid Arthritis

被引:0
|
作者
Barr, Christine [1 ]
机构
[1] Ctr Rheumatol, New York, NY 10028 USA
关键词
D O I
10.1097/01.NAN.0000264713.26219.2e
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation of the synovial membranes and progressive joint destruction. Increased understanding of the immunopathology of RA has resulted in the development of new therapies to manage the disease, including several infusion-based therapies. Abatacept, a selective costimulation modulator, has been shown to be effective in clinical trials. Abatacept has a mechanism of action that is different from any other biologic RA therapy, and it provides a valuable alternative for RA patients. This article provides practical guidance for nurses to ensure safe administration and to maximize patient outcomes with abatacept.
引用
收藏
页码:96 / 104
页数:9
相关论文
共 50 条
  • [41] Abatacept: A Review in Rheumatoid Arthritis
    Blair, Hannah A.
    Deeks, Emma D.
    DRUGS, 2017, 77 (11) : 1221 - 1233
  • [42] The pathogenesis of rheumatoid arthritis: A guide to therapy
    Jenkins, JK
    Hardy, KJ
    McMurray, RW
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2002, 323 (04): : 171 - 180
  • [43] Abatacept for subclinical rheumatoid arthritis
    Brooks, Helen
    Clark, Anna
    Van Epps, Heather
    LANCET RHEUMATOLOGY, 2022, 4 (01): : E18 - E18
  • [44] Abatacept Monotherapy Versus Abatacept Plus Methotrexate for Treatment-Refractory Rheumatoid Arthritis
    Pascart, Tristan
    Philippe, Peggy
    Drumez, Elodie
    Deprez, Xavier
    Cortet, Bernard
    Duhamel, Alain
    Houvenagel, Eric
    Flipo, Rene-Marc
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (03) : E358 - E363
  • [45] Reduction of inflammatory biomarker response by abatacept in treatment of rheumatoid arthritis
    Weisman, Michael H.
    Durez, Patrick
    Hallegua, David
    Aranda, Richard
    Becker, Jean-Claude
    Nuamah, Isaac
    Vratsanos, George
    Zhou, Ye
    Moreland, Larry W.
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (11) : 2162 - 2166
  • [46] Efficacy, safety and tolerability of using abatacept for the treatment of rheumatoid arthritis
    Venson, Rafael
    Wiens, Astrid
    Correr, Cassyano Januario
    Pontarolo, Roberto
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 48 (04) : 781 - 791
  • [47] PREDICTORS OF RESPONSE TO TREATMENT WITH ABATACEPT IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS
    Fazi, S.
    Picchianti, A.
    Podesta, E.
    Markovic, M.
    Lagana, B.
    D'Amelio, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 204 - 204
  • [48] Abatacept: A novel treatment for moderate-to-severe rheumatoid arthritis
    Reynolds, Jennifer
    Shojania, Kam
    Marra, Carlo A.
    PHARMACOTHERAPY, 2007, 27 (12): : 1693 - 1701
  • [49] Abatacept displays low levels of immunogenicity in the treatment of rheumatoid arthritis
    Haggerty, H. G.
    Abbott, M. A.
    Reilly, T. P.
    DeVona, D. A.
    Tay, L. K.
    Aranda, R.
    Block, A. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 319 - 320
  • [50] RESULTS OF ABATACEPT TREATMENT IN PATIENTS WITH DIFFERENT DURATION OF RHEUMATOID ARTHRITIS
    Kanonirova, M. A.
    Lukina, G. V.
    Sigidin, Y. A.
    Aronova, E. S.
    Glukhova, S. I.
    Luchihina, E. L.
    Karateev, D. E.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A59 - +